Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a new version of the page. This update updates the documentation/version metadata without altering the study content or visible details.
    Difference
    0.1%
    Check dated 2026-07-07T02:50:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a newer page revision.
    Difference
    0.1%
    Check dated 2026-06-29T17:50:23.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed and adds new help sections, while updating the Intervention/Treatment label and the revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:50:09.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing v3.5.4, which indicates a small platform or content update.
    Difference
    0.1%
    Check dated 2026-06-08T04:16:59.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    New page footer revision tag shows Revision: v3.5.4, and the previous Revision: v3.5.3 was removed. This is a metadata update to the page version, with no change to the study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-05-17T10:35:57.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    ClinicalTrials.gov page footer was updated from revision v3.5.2 to v3.5.3, indicating a change to the site/versioning rather than the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:36:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.